Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telbermin for Diabetic Foot Ulcers
NCT00351767Phase 2Completed
- Sponsor
- Genentech
- Start
- Jan 2006
- Primary completion
- Jan 2008
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of telbermin in diabetic foot ulcer (DFU), sponsored by Genentech. Started Jan 2006; status: completed.
02
Drugs
telbermin
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT00351767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00351767.